Page 12 - Topline News Today

Topline data expected in the second quarter of 2023 WAYNE, Pa. and ROCKVILLE, Md., Jan. 17, 2023 -- Avalo Therapeutics, Inc. , today announced that it completed enrollment of the 80... | January 17, 2023

Study successfully identified lowest effective dose1.0% formulation reached primary endpoint with statistical significanceCompany preparing for End of Phase 2 meeting with FDA following full analysisTORONTO

Topline results of the exploratory Phase 2 clinical study anticipated in Q1 2023 ... | January 10, 2023

Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety,

Of pay negotiations to be no different. if the negotiations are taking place. if you look again at the particularly in hs, the pressure people are under, the length of shift people are working, it would sound crass for ministers is suggesting they need to be more productive, when they need a more expanded workforce to meet the challenge of covid and the backlog, particularly after what has been a decade of not reasonable funding to the nhs from the government so youve got to be aware of that, bu...

My wife Jodi and I decided to ring in 2023 with our friends at Copline.org.

Anavex Life Sciences Corp. announced positive topline results from its Phase 2b/3 ANAVEX®2-73-AD-004 clinical trial of oral ANAVEX®2-73 for the treatment of mild cognitive impairment due to... | December 2, 2022

- Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities - Topline results for the Phase 3 study, LUCIDITY

In the cohort of patients enrolled before the age of 30 months, a statistically significant improvement in cognitive development (assessed by BSID-III, Bayley's Scales of Infant Development, third

-- On-track to initiate Phase 2b trial in 4Q 2022, with topline data expected in 1Q 2024 ---- Cash runway extended into 1Q 2025, pending receipt of second tranche from previously announced financing,... | November 28, 2022